East Meets West in An Incredible Partnership

The once bustling General Motors Moraine Assembly Plant located in Dayton, OH, ceased operations back in 2008 during the height of the Great Recession. The impact of the closure shook the entire region, as thousands were employed at the plant.

Watch how Woolpert and Fuyao injected new life into an abandoned plant.

While many thought the doors of the facility would remain closed forever, China’s largest auto glass manufacturer, Fuyao, saw an incredible opportunity. The company purchased the 1.4-million-square-foot plant and turned to Woolpert for help in revitalizing the space. Together, the partners created a brand-new glass manufacturing facility that provides jobs and breathes new life into the local community.

The partnership uncovered numerous differences between Chinese and U.S. business practices. Through language barriers, regulatory differences and U.S. plant operational requirements, Fuyao trusted Woolpert for guidance—and we were happy to provide it.

The unique collaboration proved to be a very rewarding experience for Fuyao. The striking success of the adaptive reuse project led to an increased financial investment (from $230 million to $360 million) and doubled employment estimate (from 800 to 1,550). The project also turned out to be a win for the city of Dayton, which now enjoys new opportunities for economic growth and sees a community rejuvenated with fresh inspiration and vitality.

For Woolpert, the benefits have been both personal and professional. “Getting to know Fuyao and how the Chinese do business, along with seeing how they execute projects, has been very educational and enriching,” said Jamie Dobrozsi, Woolpert Project Manager. “We developed a genuine relationship. We’ve spent holidays together. Our team even went to China to better understand their specific needs, and we were treated so well.”

This successful partnership wouldn’t have been possible without one essential element: trust. Trust is extremely important in the Chinese culture, and Woolpert was honored that Fuyao trusted us to bring their vision to fruition. What began as a business partnership has developed into a genuine relationship, and we can’t wait to see our friends from the East again. “I look forward to continuing our relationship, and I plan to get back to China for another visit soon,” Dobrozsi promised.

Read more at woolpert.com

Follow us on social media for the latest updates in B2B!

Image

Latest

personal branding
Personal Branding Now Drives B2B Success, Customer Trust, and Competitive Advantage
December 5, 2025

Personal branding has rapidly shifted from a “nice-to-have” to a strategic imperative in B2B marketing, reshaping how companies communicate, differentiate, and build trust. As industries evolve and professionals take on more dynamic, multi-stream careers, visibility and authenticity have become critical assets. Key findings from the Edelman + LinkedIn Thought Leadership Impact Report show that…

Read More
IT
Real-World IT Practices Are Streamlining AV Deployments and Raising the Bar for Consistency
December 4, 2025

For years, the AV industry has discussed the long-anticipated convergence with IT—but that shift is no longer theoretical. With cloud adoption accelerating, hybrid work normalizing, and organizations rebuilding digital infrastructure after years of rapid change, AV systems now sit squarely on the IT backbone. In fact, the majority of newly upgraded conference rooms require network-centric…

Read More
ROI
ROI Case Study
December 3, 2025

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Read More
coverage
Clip 2 – Fighting for Coverage: One Patient’s Story
December 3, 2025

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

Read More